65,437 trials
Hearing Loss, Unilateral
Primary: Change Over Time in the Ability to Perceive Single Words as Assessed by Consonant-Nucleus-Consonant (CNC) Word Recognition Testing — 1.4; 14.4; 28.2; 45.0 percentage of…
Congestive Heart Failure
Primary: Change From Baseline in Body Weight — -1.67; -1.36 kg
Healthy Volunteers
Primary: Maximum Observed Plasma Concentration (Cmax) of Apremilast — 323; 274; 215 ng/mL
Healthy
Primary: Phonation Threshold Pressure — 5.41; 5.08; 6.39; 6.33 cmH20 — p=<0.001
Diabetes
Primary: Mean Daily Blood Glucose by POC Reading сompared to CGM Reading — 175.55; 175.84 mg/dL
Severe Vasomotor Symptom Associated With Menopause
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 73; 2 Participants
Heart Failure · ICD · Chronotropic Incompetence
Primary: Six-minute Walk Distance (6MWD) Test — 293.1; 315.1 meters
Pain, Acute · Pain, Chronic
Primary: PROMIS - Physical Function Short Form 8b — 34.5; 38.6 units on a scale — p=.111
Aging
Primary: Number of Participants With Increased Need for Assistance During 3-year Study Period — 13; 16 Participants
Metastatic Melanoma
Primary: Response Rate: The Number of Participants Who Completed the Maximum Time Allowed on Study Without Being Affected by Tumor Recurrence or Progression. — 0 Participants
Medium and Lower Rectal Cancer
Primary: Absence at Day 30 of a Symptomatic Anastomotic Leakage (AL) Among 2SCA — 1 Participants
Epilepsy With POS With or Without Secondary Generalization
Primary: Percentage of Participants Remaining in the Study and on BRV Treatment at Month 12 — 57.7 percentage of participants
Healthy
Primary: Number of Participants With Adverse Reaction (AE) and Severe Adverse Reaction (SAE) — 1; 0; 0; 0 Participants
Lichen Planus
Primary: Change in Modified Clinical Assessment Scale of Severity for Index Lesion Signs and Symptoms (mCAILS) — 11.0 score on a scale
HIV in MSM
Primary: Depression — 22.10; 20.35 score on a scale